Amy Elazzouzi
Vermögen: 901 808 $ am 30.09.2026
Vermögen: 901 808 $ am 30.09.2026
Amy Elazzouzi is currently Principal Financial Officer, Secretary & Treasurer at Aura Biosciences, Inc. since 2026.
Former positions include Director-Finance & Operations at Kew, Inc. and Controller at AVEO Pharmaceuticals, Inc. Education includes an MBA from Northeastern University and an undergraduate degree from Regis College.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
AURA BIOSCIENCES INC 0,14 % | 01.09.2026 | 143.600 ( 0,14 % ) | 901 808 $ | 30.09.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| AURA BIOSCIENCES, INC. | Finanzdirektor/CFO | 02.09.2026 |
| Unternehmen | Position | Ende |
|---|---|---|
| AVEO PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | - |
Kew, Inc.
Kew, Inc. Medical/Nursing ServicesHealth Services Provides oncology services | Finanzdirektor/CFO | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Aura Biosciences, Inc.
Aura Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company leveraging novel targeted oncology platform to develop new standard of care across multiple cancer indications | Health Technology |
Northeastern University
Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Regis College
Regis College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AVEO Pharmaceuticals, Inc.
AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops cancer therapeutics | Health Technology |
Kew, Inc.
Kew, Inc. Medical/Nursing ServicesHealth Services Provides oncology services | Health Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen